Experienced in Low Potassium Level

Laurent Argaud

Faculté De Médecine Lyon Est, 
Lyon, FR 
Experienced in Low Potassium Level
Faculté De Médecine Lyon Est, 
Lyon, FR 
OverviewLocationsClinical Research

Overview

Laurent Argaud practices in Lyon, France. Mr. Argaud is rated as an Experienced expert by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Pneumonia, Sepsis, and Severe Acute Respiratory Syndrome (SARS).

His clinical research consists of co-authoring 324 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Low Potassium Level.

Gender
Male

Locations

Faculté De Médecine Lyon Est, Lyon, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Assessment of Therapeutic Plasma Exchange to Improve Respiratory Function by Alleviating Cytokine Storm During Severe Covid-19 Infections Randomised Open-label Controlled Trial
Assessment of Therapeutic Plasma Exchange to Improve Respiratory Function by Alleviating Cytokine Storm During Severe Covid-19 Infections Randomised Open-label Controlled Trial
Enrollment Status: Completed
Publish Date: September 03, 2025
Intervention Type: Other
Study Phase: Not Applicable
A Double-Blind, Randomized, Placebo-controlled Multicenter Trial of GRanulocyte-Macrophage Colony-stimulating Factor Administration to Decrease ICU Acquired Infections in Sepsis-induced ImmunoDepression
A Double-Blind, Randomized, Placebo-controlled Multicenter Trial of GRanulocyte-Macrophage Colony-stimulating Factor Administration to Decrease ICU Acquired Infections in Sepsis-induced ImmunoDepression
Enrollment Status: Completed
Publish Date: September 03, 2025
Intervention Type: Drug
Study Phase: Phase 3
Value of Early Treatment With Polyvalent Immunoglobulin in the Management of Acute Respiratory Distress Syndrome Associated With SARS-CoV-2 Infections
Value of Early Treatment With Polyvalent Immunoglobulin in the Management of Acute Respiratory Distress Syndrome Associated With SARS-CoV-2 Infections
Enrollment Status: Completed
Publish Date: August 19, 2021
Intervention Type: Drug
Study Drug: Human Immunoglobulin
Study Phase: Phase 3
Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU
Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU
Enrollment Status: Completed
Publish Date: March 30, 2021
Prevalence Study : Elderly Patients and Rehabilitation in ICU. Impact of Frailty.
Prevalence Study : Elderly Patients and Rehabilitation in ICU. Impact of Frailty.
Enrollment Status: Completed
Publish Date: August 14, 2019
Intervention Type: Other
Identification, in Patients Admitted to Intensive Care for Severe Influenza Respiratory Infection, of a Predictive Biomarker of Respiratory Distress
Identification, in Patients Admitted to Intensive Care for Severe Influenza Respiratory Infection, of a Predictive Biomarker of Respiratory Distress
Enrollment Status: Completed
Publish Date: February 19, 2019
Intervention Type: Other
Study Phase: Not Applicable
Impact on Mortality of the Timing of Renal Replacement Therapy in Patients With Severe Acute Kidney Injury in Septic Shock: the IDEAL-ICU Study (Initiation of Dialysis Early Versus Delayed in the Intensive Care Unit): Study Protocol for a Randomized Controlled Trial
Impact on Mortality of the Timing of Renal Replacement Therapy in Patients With Severe Acute Kidney Injury in Septic Shock: the IDEAL-ICU Study (Initiation of Dialysis Early Versus Delayed in the Intensive Care Unit): Study Protocol for a Randomized Controlled Trial
Enrollment Status: Terminated
Publish Date: November 27, 2018
Intervention Type: Procedure
Study Phase: Phase 3
View 6 Less Clinical Trials

324 Total Publications

Publisher Correction: Monocyte HLA-DR expression in septic shock patients: insights from a 20-year real-world cohort of 1023 cases.
Publisher Correction: Monocyte HLA-DR expression in septic shock patients: insights from a 20-year real-world cohort of 1023 cases.
Journal: Intensive care medicine
Published: October 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Argaud's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 51 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile